CHANG SHIH CHANG: A method for fabricating thin touch sensor panels. Apple, Kubota Glenn M, July 15, 2010: WO/2010/080988 (19 worldwide citation)

A method for fabricating thin DITO or SITO touch sensor panels with a thickness less than a minimum thickness tolerance of existing manufacturing equipment. In one embodiment, a sandwich of two thin glass sheets is formed such that the combined thickness of the glass sheets does not drop below the m ...

COSTELLO DONALD: Method for treating hyperglycemia with glp-1. MANNKIND CORPORATION, Cullman Louis C, July 15, 2010: WO/2010/080964 (17 worldwide citation)

A method for treating hyperglycemia and/or diabetes in a subject is provided. In particular, the method is directed for the treatment of patients with type 2 diabetes mellitus who have a fasting blood glucose concentration greater than about 8 mM, wherein the patient is administered a formulation co ...

VAN ALSTINE JAMES: Separation method using single polymer phase systems. GE HEALTHCARE BIO SCIENCES, Ge Healthcare Bio Sciences, July 15, 2010: WO/2010/080062 (17 worldwide citation)

The present invention relates to a process of enriching one target compound from a liquid, which process comprises at least one step of isolation performed by differentially partitioning between two aqueous phases. In the present invention the phases are formed by adding a thermally responsive, self ...

STAGLIANO NANCY E: Modified antibody compositions, methods of making and using thereof. CYTOMX THERAPEUTICS, Roy Madhuri, July 15, 2010: WO/2010/081173 (14 worldwide citation)

The present disclosure provides modified antibodies which contain an antibody or antibody fragment (AB) modified with a masking moiety (MM). Such modified antibodies can be further coupled to a cleavable moiety (CM), resulting in activatable antibodies (AAs), wherein the CM is capable of being cleav ...

HAAR JR JOSEPH P: Synthesis of methylphenidate and analogs thereof. MALLINCKRODT, Siman Craig D, July 15, 2010: WO/2010/080787 (14 worldwide citation)

A synthetic process for the preparation of amino acid esters such as methylphenidate and analogs thereof is disclosed. The process involves reacting an amino acid such as α-phenyl-α-(2-piperidinyl)acetic acid or an analog thereof with an alcohol such as methanol in the presence of an acid and a wate ...

LINK JOHN O: Hcv ns3 protease inhibitors. GILEAD SCIENCES, Mcgurl Barry F, July 15, 2010: WO/2010/080389 (14 worldwide citation)

The present invention relates to macrocyclic compounds of formula (Ia) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

DIMARCHI RICHARD D: Amide-based insulin prodrugs. INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION, Breen John P, July 15, 2010: WO/2010/080609 (13 worldwide citation)

Prodrug formulations of insulin and insulin analogs are provided wherein the insulin peptide has been modified by an amide bond linkage of a dipeptide prodrug element. The prodrugs disclosed herein have extended half lives of at least 10 hours, and more typically greater than 2 hours, 20 hours and l ...

SCHULTZ WILLIAM J: Nanocalcite composites. 3M INNOVATIVE PROPERTIES COMPANY, Spielbauer Thomas M, July 15, 2010: WO/2010/080459 (13 worldwide citation)

Compositions comprising surface-modified nanocalcite particles dispersed in a curable resin, and to coatings and fibrous composites incorporating such compositions are described. The surface-modifying agents include a binding group ionically associated with the calcite and a compatiblizing segment, ...

NILSSON HENRIK: Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix. FORWARD PHARMA, Stahr Pia, July 15, 2010: WO/2010/079222 (12 worldwide citation)

A pharmaceutical formulation comprising an erosion matrix comprising one or more fumaric acid esters as well as one or more rate-controlling agents, wherein erosion of said erosion matrix permits controlled release of said fumaric acid ester(s).

HU DEAN: Reduced pressure therapy of the sacral region. SPIRACUR, Wu Walter, July 15, 2010: WO/2010/080907 (12 worldwide citation)

Reduced pressure wound therapy is performed on a sacral region of a patient using an adhesive dressing comprising a flexible planar layer and a non-planar fold-sealing region configured to seal to the intergluteal cleft of a patient. The fold-sealing region is located on an outer edge of the adhesiv ...

Click the thumbnails below to visualize the patent trend.